Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203358 · ClinicalTrials.gov registry record · Phase 2
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
A Phase 2 study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- Phase 2
- Development phase
- 617
- Enrollment target
NCT01203358: Completed Phase 2 study, sponsored by NICHD Neonatal Research Network.
NCT01203358 is a Phase 2 study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 617 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (364% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01203358, a Phase 2 study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 617 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome.
Interventions
- DRUG Exosurf
- DRUG Survanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 617 participants |
| Start Date | 1991-01 |
| Est. Completion | 1992-01 |
| Phase | Phase 2 |
What the finished NCT01203358 record still lists
NCT01203358 is an interventional study that assigns participants to a tested intervention. The registered 617 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (364% higher).
The record links to 0 conditions, and to 2 interventions - of which Exosurf is the first listed.
NCT01203358 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01203358 about?
NCT01203358 is a clinical study titled "Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome". The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome.
What is the current status of trial NCT01203358?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 617 participants. The study started on 1991-01. Estimated completion is 1992-01.
What interventions are being tested in trial NCT01203358?
The interventions under investigation include: Exosurf (DRUG), Survanta (DRUG).
Who is sponsoring clinical trial NCT01203358?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01203358's enrollment target sits among peer trials
617 53rd of 2000 higher than 1,948 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02610179 · 617 participants · NA
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
- NCT05672927 · 618 participants · Phase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
- NCT06220721 · 618 participants · NA
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
- NCT04813185 · 616 participants · NA
Preventing Retaliatory Gun Violence in Violently Injured Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia